Pharmacists step in to tackle diabetes crisis

NCT ID NCT07339852

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a pharmacist-led care pathway can improve blood sugar control in 600 adults with type 2 diabetes who are not meeting their A1C targets. Participants will receive step-by-step guidance from pharmacists using a web-based tool, compared to usual care from their doctor or nurse. The goal is to see if this approach helps people achieve healthier blood sugar levels and reduce the risk of diabetes-related complications.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Pharmacist-led diabetes care pathway
What this could lead to
If successful, this could show that pharmacist-led care helps people with type 2 diabetes achieve better blood sugar control and lower their risk of complications.
What could go wrong
This is a relatively small, early-stage study (600 participants) comparing a new care pathway to usual care. Results may not apply to all settings, and the intervention may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alberta

    RECRUITING

    Edmonton, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.